Literature DB >> 22439857

Paternal drug use: before and during pregnancy.

Ineke Crijns1, Jens Bos, Marissa Knol, Sabine Straus, Lolkje de Jong-van den Berg.   

Abstract

OBJECTIVE: Exploratory investigation on drug use by fathers before and during pregnancy with regard to the number of pregnancies. RESEARCH DESIGN AND METHODS: Data of Dutch community pharmacies were used in which fathers were linked to children. The prevalence of the 15 most prescribed drug groups were calculated per trimester for one trimester preconception and three trimesters during pregnancy. Drugs with possible harmful effect on the semen and/or embryo based on recent safety issues were analyzed for two trimesters before conception. Descriptive statistics was used.
RESULTS: During the four trimesters, fathers had used one or more drugs in 73% of the pregnancies. Per trimester, drug use ranged from 35 to 39%, with the highest prevalence in the third trimester, statistically significant for the use of one or two drugs. Drugs used most frequently belong to 'anti-inflammatory and antirheumatic products'. Drugs such as SSRIs with possible harmful effect on the semen and/or embryo are used in 1.4% by fathers before conception.
CONCLUSION: A proportion of 73% of fathers used drugs before and during pregnancy, increasing toward the third trimester. To increase the knowledge on possible effects, organizations like EUROCAT and (EN)(O)TIS might be encouraged to also collect paternal drug use.

Entities:  

Mesh:

Year:  2012        PMID: 22439857     DOI: 10.1517/14740338.2012.674109

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  5 in total

1.  Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.

Authors:  Anders Engeland; Tone Bjørge; Anne Kjersti Daltveit; Svetlana Skurtveit; Siri Vangen; Stein Emil Vollset; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

2.  Investigating paternal preconception risk factors for adverse pregnancy outcomes in a population of internet users.

Authors:  Eleonora Agricola; Francesco Gesualdo; Emanuela Carloni; Angelo D'Ambrosio; Luisa Russo; Ilaria Campagna; Elisabetta Pandolfi; Alberto E Tozzi
Journal:  Reprod Health       Date:  2016-04-14       Impact factor: 3.223

3.  Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.

Authors:  Fen Yang; Jianping Chen; Mao-Hua Miao; Wei Yuan; Lin Li; Hong Liang; Vera Ehrenstein; Jiong Li
Journal:  BMJ Open       Date:  2017-12-22       Impact factor: 2.692

4.  Preparation for fatherhood: A survey of men's preconception health knowledge and behaviour in England.

Authors:  Jill Shawe; Dilisha Patel; Mark Joy; Beth Howden; Geraldine Barrett; Judith Stephenson
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

5.  The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Authors:  L F Perez-Garcia; R J E M Dolhain; S Vorstenbosch; W Bramer; E van Puijenbroek; J M W Hazes; B Te Winkel
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.